[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "SRM OR FDR EFO biosample accession number proteomics data acquisition method README FITNESS MONDO IAA THAT CN PURPOSE ... LIMITED SHALL WILL OF II MOD fraction identifier MAJOR PS DISCLAIMS NOT VK PRM VCF SWATH IS organism part SP TAB BTO MUST BMC technical replicate PMCID dissociation method CL HTML developmental stage IMPORTANT BE CS CPTAC MAY cell type NOTE PP EXPRESS NT replicate CLO source name_ and _assay name PATCH REQUIRES PROTEOMICS INFORMATION SDRF INFRINGE characteristics RFC COULD HCD HEREIN ZFA MS WARRANTIES EM mass LI sample TIP DTT AS PTM PARTICULAR THE XML CID spiked compound depletion STANDARDS age instrument SN XL PMID QY WARRANTY DJ MC disease HUPO SHOULD PO MHC alkylation reagent OPTIONAL biological replicate COLUMN PSI data file JA cleavage agent details MAGE MS:1001251 ALL UBERON MT ID DDA IDF DOID EBI ancestry category source name PRIDE:0000659 CV ISA LC MERCHANTABILITY PRIDE FOR collision energy NCBI exclamation MIAME EW BRENDA RAW disease stage TA SH pooled sample DIA URI SILAC label NCE IMPLIED CELL REQUIRED CF HF sex reduction reagent III TO ROW RIGHTS INCLUDING TMT ENVO AC file your organism CT INITIATIVE BUT USE RECOMMENDED individual fractionation method URL HANCESTRO MINOR RECOMMEND PATO ANY PEPTIDESEQ"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "SRM OR FDR EFO biosample accession number proteomics data acquisition method README FITNESS MONDO IAA THAT CN PURPOSE ... LIMITED SHALL WILL OF II MOD fraction identifier MAJOR PS DISCLAIMS NOT VK PRM VCF SWATH IS organism part SP TAB BTO MUST BMC technical replicate PMCID dissociation method CL HTML BE CS CPTAC MAY cell type PP EXPRESS NT CLO PATCH REQUIRES PROTEOMICS INFORMATION SDRF INFRINGE RFC COULD HCD HEREIN ZFA MS WARRANTIES EM mass LI DTT AS PTM PARTICULAR THE CID spiked compound depletion STANDARDS age instrument SN XL PMID QY WARRANTY DJ MC disease HUPO SHOULD PO MHC alkylation reagent OPTIONAL biological replicate COLUMN PSI data file JA cleavage agent details MAGE MS:1001251 ALL UBERON MT DDA IDF DOID EBI ancestry category PRIDE:0000659 CV ISA LC MERCHANTABILITY PRIDE FOR collision energy NCBI MIAME EW BRENDA RAW disease stage TA SH pooled sample DIA URI SILAC label NCE IMPLIED CELL REQUIRED CF HF sex reduction reagent III TO ROW RIGHTS INCLUDING TMT ENVO AC organism CT INITIATIVE BUT USE RECOMMENDED individual fractionation method URL HANCESTRO MINOR RECOMMEND PATO ANY PEPTIDESEQ"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "CL:0000233 CL:0000236 EFO CL:0000625 DSS MONDO NK MONDO:0005105 MONDO:0004975 MONDO:0005138 UBERON:0000948 CL:0000788 xenograft MONDO:0005148 CL:0000624 CL:0000057 organism part MUST CSF UBERON:0000955 UBERON:0000310 CL developmental stage UBERON:0001155 IMPORTANT CL:0000576 NSG MONDO:0005180 UBERON:0002097 MONDO:0005575 CL:0000066 MAY cell type NOTE SDRF CL:0000898 UBERON:0001977 TIP CL:0000232 UBERON:0002113 PTM PATO:0000383 COVID depletion age synthetic peptide CL:0000813 CL:0000451 UBERON:0001088 MONDO:0100096 disease SHOULD PO biological replicate UBERON:0002107 ALL PDX UBERON CL:0000084 ID DOID ancestry category PATO:0001340 source name enrichment process UBERON:0001969 exclamation NCBI CL:0000913 CL:0000540 MONDO:0008383 UBERON:0000178 CL:0000182 CL:0000815 CL:0000235 lib CL:0000787 UBERON:0002048 PATO:0000384 sex MONDO:0005301 APP CML organism disease model MONDO:0004989 individual MONDO:0004946 compound URL PATO:0000461 HANCESTRO UBERON:0001359 PATO CL:0000623"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "CL:0000233 CL:0000236 EFO CL:0000625 DSS MONDO NK MONDO:0005105 MONDO:0004975 MONDO:0005138 UBERON:0000948 CL:0000788 xenograft MONDO:0005148 CL:0000624 CL:0000057 organism part MUST CSF UBERON:0000955 UBERON:0000310 CL developmental stage UBERON:0001155 CL:0000576 NSG MONDO:0005180 UBERON:0002097 MONDO:0005575 CL:0000066 MAY cell type SDRF CL:0000898 UBERON:0001977 CL:0000232 UBERON:0002113 PTM PATO:0000383 COVID depletion age synthetic peptide CL:0000813 CL:0000451 UBERON:0001088 MONDO:0100096 disease SHOULD PO biological replicate UBERON:0002107 ALL PDX UBERON CL:0000084 ID DOID ancestry category PATO:0001340 source name enrichment process UBERON:0001969 NCBI CL:0000913 CL:0000540 MONDO:0008383 UBERON:0000178 CL:0000182 CL:0000815 CL:0000235 CL:0000787 UBERON:0002048 PATO:0000384 sex MONDO:0005301 APP CML organism disease model MONDO:0004989 individual MONDO:0004946 compound URL PATO:0000461 HANCESTRO UBERON:0001359 PATO CL:0000623"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C14169 ACE EFO NCIT:C65106 NCIT:C15329 NCIT:C53554 NCIT:C4870 UO NCIT:C15262 MONDO NCIT:C14168 NCIT:C62723 breast cancer subtype ethnicity AJCC treatment IV NCIT:C28054 NCIT:C18058 II CHEBI:6801 NCIT:C28077 NCIT:C14174 BMI CHEBI:28748 NCIT:C28078 MONDO:0005148 MONDO:0002050 NCI diet organism part PR treatment status weight CHEBI:27899 NCIT:C27970 gestational age IMPORTANT PD NCIT NCIT:C16358 NOTE Dukes stage NCIT:C15632 SDRF time post treatment NCIT:C81328 TNM NCIT:C18213 MONDO:0005300 MONDO:0004995 NCIT:C27966 NCIT:C14167 CHEBI:41774 HANCESTRO:0010 age Ann Arbor stage secondary condition pre-existing condition dose HANCESTRO:0009 ER disease MONDO:0004979 NCIT:C53555 HANCESTRO:0005 NCIT:C15445 NCIT:C53553 TNM staging NCIT:C28076 NCIT:C28079 ID NCIT:C53556 sampling time point ancestry category alcohol consumption PREFERRED NCIT:C65108 MONDO:0011122 NCIT:C18206 tumor grade MONDO:0005044 exclamation medication history disease stage pregnancy status prior treatment NCIT:C68804 HIPAA sex III GDPR NCIT:C81327 body mass index smoking status height NCIT:C71732 treatment response NCIT:C15313 menopausal status HANCESTRO:0006 organism NCIT:C27971 individual compound HANCESTRO NCIT:C65107"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "NCIT:C14169 ACE EFO NCIT:C65106 NCIT:C15329 NCIT:C53554 NCIT:C4870 UO NCIT:C15262 MONDO NCIT:C14168 NCIT:C62723 breast cancer subtype ethnicity AJCC treatment IV NCIT:C28054 NCIT:C18058 II CHEBI:6801 NCIT:C28077 NCIT:C14174 BMI CHEBI:28748 NCIT:C28078 MONDO:0005148 MONDO:0002050 NCI diet organism part PR treatment status weight CHEBI:27899 NCIT:C27970 gestational age PD NCIT NCIT:C16358 Dukes stage NCIT:C15632 SDRF time post treatment NCIT:C81328 TNM NCIT:C18213 MONDO:0005300 MONDO:0004995 NCIT:C27966 NCIT:C14167 CHEBI:41774 HANCESTRO:0010 age Ann Arbor stage secondary condition pre-existing condition dose HANCESTRO:0009 ER disease MONDO:0004979 NCIT:C53555 HANCESTRO:0005 NCIT:C15445 NCIT:C53553 TNM staging NCIT:C28076 NCIT:C28079 ID NCIT:C53556 sampling time point ancestry category alcohol consumption PREFERRED NCIT:C65108 MONDO:0011122 NCIT:C18206 tumor grade MONDO:0005044 medication history disease stage pregnancy status prior treatment NCIT:C68804 HIPAA sex III GDPR NCIT:C81327 body mass index smoking status height NCIT:C71732 treatment response NCIT:C15313 menopausal status HANCESTRO:0006 organism NCIT:C27971 individual compound HANCESTRO NCIT:C65107"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "SRM MS1 scan range MUST RAW MS:1001303 technical replicate scan window lower limit XL TA DIA ST MS:1001917 SILAC URI TOF IMPORTANT RPPA label proteomics data acquisition method FTP PRIDE:0000663 MSD MGF SHOULD REQUIRED CS CF HF PP NOTE LTQ NT MS:1001306 fragment mass tolerance MS2 analyzer type SDRF PSI TMT data file cleavage agent details UNIMOD MS:1001251 MS:1001309 MS MM MT scan window upper limit MOD ID DDA AC fraction identifier UNIMOD:21 ELISA TS UNIMOD:737 KR sample TIP UNIMOD:1 RECOMMENDED SCIEX PRM modification parameters proteomexchange accession number URL file uri UNIMOD:4 UNIMOD:35 MS:1001313 PRIDE exclamation fraction instrument MRM precursor mass tolerance"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "SRM MS1 scan range MUST RAW MS:1001303 technical replicate scan window lower limit XL TA DIA ST MS:1001917 SILAC URI TOF label proteomics data acquisition method FTP PRIDE:0000663 MSD PRIDE MGF SHOULD REQUIRED CS CF HF PP LTQ NT MS:1001306 fragment mass tolerance MS2 analyzer type SDRF PSI TMT data file cleavage agent details UNIMOD MS:1001251 MS:1001309 MS MM MT scan window upper limit MOD ID DDA AC fraction identifier UNIMOD:21 ELISA TS UNIMOD:737 KR UNIMOD:1 RECOMMENDED SCIEX PRM modification parameters proteomexchange accession number URL file uri UNIMOD:4 UNIMOD:35 MS:1001313 RPPA instrument MRM precursor mass tolerance"
  }
]